| Name | N-[2-(2-Methylbenzyl)-3-sulfanylpropanoyl]-L-methionine |
|---|---|
| Synonyms |
(R,R)-formoterol fumarate
N-[2-mercaptomethyl-3-(2-methylphenyl)propionyl]-methionine N-[2-mercaptomethyl-3-(2-methylphenyl)propioyl]-methionine N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-(4-methoxyphenyl)-1-methylethyl]-amino]ethyl]phenyl]formamide (2S)-2-(3-mercapto-2-(2-methylbenzyl)propanamido)-4-(methylthio)butanoic acid Eformoterol fumarate FORMATEROL FUMATATE NIN 2,NIN2 2-[[2-[(2-Methylphenyl)methyl]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoic acid L-Methionine, N-[2-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl] FarMeterol N-(2(S)-(Mercaptomethyl)-3-(2-Methylphenyl)-1- Oxopropyl)-L-Methionine ForMaterol FuMarate Aformoterol N-IN-2 |
| Description | NEP-IN-2 is an inhibitor of neutral endopeptidase, used in the research of proliferation in atherosclerosis, restenosis. |
|---|---|
| Related Catalog | |
| Target |
Neutral endopeptidase[1] |
| In Vitro | NEP-IN-2 is an inhibitor of neutral endopeptidase (NEP), used in the research of proliferation in atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis or other diseases involving vascular cell proliferation[1]. |
| References |
| Density | 1.204g/cm3 |
|---|---|
| Boiling Point | 603ºC at 760 mmHg |
| Molecular Formula | C16H23NO3S2 |
| Molecular Weight | 341.48900 |
| Flash Point | 318.5ºC |
| Exact Mass | 341.11200 |
| PSA | 133.99000 |
| LogP | 3.24630 |
| Vapour Pressure | 2.16E-15mmHg at 25°C |
| Index of Refraction | 1.578 |